comprehensive -WSS

comprehensive

author：comprehensive 2025-09-28 10:52:48 - browse：3

Sarepta - Cambridge -AP — Kristoffer Tripplaar/Sipa via AP

The Food and Drug Administration granted conditional approval Thursday to the first gene therapy for Duchenne muscular dystrophy. Regulators restricted the treatment to younger patients, with additional data required to broaden its use.

The gene therapy, called Elevydis, is made by Sarepta Therapeutics. The company will charge $3.2 million for the treatment, making it the U.S.’s second most expensive drug, behind a recently approved gene therapy for hemophilia. CEO Doug Ingram said on a conference call the price was below what a recently published company-funded analysis found would be cost-effective.

“The approval of Elevidys is a watershed moment for the treatment of Duchenne. Elevydis is the first and only gene therapy approved for Duchenne, and this approval brings us closer to our goal of bringing forward a treatment that provides the potential to alter the trajectory of this degenerative disease,” Ingram said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Menendez indictment could see pharma lose a key ally

explore

WSS

How to save health care price transparency rules

After a drawn out lobbying fight, ARPA

How one patient went off dialysis — and others can too

UCLA team creates talking throat patch for voice disorders

HHS secretary Becerra pressed on Change HealthCare cyberattack

Why scientists need input from humanists on sensitive research

hotspot

comprehensive

hotspot

Medicare details structure of new drug price negotiation program

Boston's new lab space is opening empty

State Dept. review finds Biden bears some blame for Afghanistan failures

STAT Virtual Event: How to Increase Diversity in Clinical Trials

BioMarin wins approval for gene therapy to treat hemophilia A

Ionis has late

What does generative AI mean for health care? We asked experts

Researchers use wearables data and AI to predict preterm birth risk

Medicare proposal to cover medical devices draws a mixed reaction

As AI in medicine takes off, can 'human in the loop' prevent harm?

hotspot

How one patient went off dialysis — and others can too

EPA limits use of carcinogenic gas for sterilizing medical devices

Change Healthcare outage fallout shows need for new oversight

Why depression after traumatic brain injury is distinct

Change Healthcare outage fallout shows need for new oversight

Data show record exodus of life scientists from academia

explore

knowledge

Wikipedia

leisure time